ABSTRACT
Most approaches targeting the immune system against tumors have focused on patients with established tumors. However, whether the immune system can recognize preneoplastic stages of human cancer is not known. Here we show that patients with preneoplastic gammopathy mount a vigorous T cell response to autologous premalignant cells. This preneoplasia-specific CD4+ and CD8+ T cell response is detected in freshly isolated T cells from the BM. T cells from myeloma marrow lack this tumor-specific rapid effector function. These data provide direct evidence for tumor specific immune recognition in human preneoplasia and suggest a possible role for the immune system in influencing the early growth of transformed cells, long before the development of clinical cancer.
Subject(s)
Bone Marrow Cells/immunology , Paraproteinemias/immunology , Precancerous Conditions/immunology , T-Lymphocytes/immunology , Flow Cytometry , Humans , Interferon-gamma/biosynthesisABSTRACT
We studied the function of antitumor T and natural killer T (NKT) cells from the blood and tumor bed in 23 patients with premalignant gammopathy, nonprogressive myeloma, or progressive multiple myeloma. We show that antitumor killer T cells can be detected in patients with both progressive or nonprogressive myeloma. V alpha 24+V beta 11+ invariant NKT cells are detectable in the blood and tumor bed of all cohorts. However, freshly isolated NKT cells from both the blood and tumor bed of patients with progressive disease, but not nonprogressive myeloma or premalignant gammopathy, have a marked deficiency of ligand-dependent interferon-gamma production. This functional defect can be overcome in vitro using dendritic cells pulsed with the NKT ligand, alpha-galactosylceramide (alpha-GalCer). Fresh myeloma cells express CD1d, and can be efficiently killed by autologous NKT cells. We hypothesize that presentation of tumor derived glycolipids by myeloma cells leads to NKT dysfunction in vivo. These data demonstrate that clinical progression in patients with monoclonal gammopathies is associated with an acquired but potentially reversible defect in NKT cell function and support the possibility that these innate lymphocytes play a role in controlling the malignant growth of this incurable B cell tumor in patients.
Subject(s)
Killer Cells, Natural/immunology , Multiple Myeloma/immunology , Multiple Myeloma/pathology , Precancerous Conditions/immunology , Precancerous Conditions/pathology , T-Lymphocyte Subsets/immunology , Antigens, CD1/metabolism , Antigens, CD1d , Biomarkers , Cells, Cultured , Cytotoxicity, Immunologic , Dendritic Cells/metabolism , Disease Progression , Humans , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-4/immunology , Interleukin-4/metabolism , Killer Cells, Natural/metabolism , Paraproteinemias/immunology , Paraproteinemias/metabolism , T-Lymphocyte Subsets/metabolismABSTRACT
A 72-year-old man was hospitalized for transurethral resection of bladder cancer. Two days after the procedure, the patient continued to have gross hematuria and a computed tomography (CT) scan of the abdomen and pelvis with intravenous contrast was performed to check the integrity of the resection site. Later that day, the patient underwent technetium-99m methylene diphosphonate (MDP) bone scintigraphy to investigate the possibility of bone metastasis. The bone scan showed no signs of metastasis but did reveal increased uptake of the left hand and forearm on the opposite side of the injection site.
Subject(s)
Compartment Syndromes/chemically induced , Compartment Syndromes/diagnostic imaging , Injections/adverse effects , Radiopharmaceuticals/adverse effects , Technetium Tc 99m Medronate/adverse effects , Aged , Arm , Humans , Male , Radiopharmaceuticals/administration & dosage , Technetium Tc 99m Medronate/administration & dosage , Tomography, Emission-Computed , Tomography, X-Ray Computed , Urinary Bladder Neoplasms/pathologyABSTRACT
Abscess formation after abdominal surgery is not an uncommon complication. It is much less common for a collection to be the result of a fistulous tract from the bowel. We describe a patient who underwent a Tc-99m hepatobiliary (Choletec) scan for the workup of a perihepatic abscess, which confirmed the presence of a fistulous tract from the small bowel to a perihepatic collection.
Subject(s)
Biliary Fistula/diagnostic imaging , Intestine, Small/abnormalities , Intestine, Small/diagnostic imaging , Liver Abscess/diagnostic imaging , Liver Abscess/etiology , Female , Humans , Middle Aged , Radionuclide ImagingABSTRACT
Cancer/testis (CT) antigens are expressed in several malignant tumors, but not in normal tissues except for testicular germ cells. The expression of CT antigenic proteins in malignant gammopathies has not been characterized. We examined the expression of a panel of CT antigenic proteins in 29 patients with malignant gammopathies by immunohistochemistry using the following monoclonal antibodies (mAbs): mAb MA454 to MAGE-A1, mAb M3H67 to MAGE-A3, mAb 57B to MAGE-A4, mAb CT7-33 to CT7/MAGE-C1 and mAb ES121 to NY-ESO-1. We could detect at least one CT antigen in tumors from 27 of 29 patients. The expression pattern of MAGE-A1, -A3, -A4 and NY-ESO-1 is heterogeneous in most cases, revealing staining in <25% of the tumor cells. Monoclonal antibodies CT7-33 and M3H67 show the highest incidence of immunoreactivity. Importantly, CT-7 can also be detected on the surface of some myeloma cells by flow cytometry, and in one plasmacytoma case by immunohistochemistry. Expression of CT antigens is greater in patients with stage III extramedullary plasmacytoma or high-risk myeloma relative to other cohorts. These data suggest that CT antigens may have important biological implications in malignant gammopathies and that CT-7 may be a suitable target for T cell-based and possibly antibody-mediated immunotherapy of myeloma.
Subject(s)
Antigens, Neoplasm/biosynthesis , Membrane Proteins , Multiple Myeloma/metabolism , Plasmacytoma/metabolism , Adult , Aged , Aged, 80 and over , Humans , Immunohistochemistry , Melanoma-Specific Antigens , Middle Aged , Multiple Myeloma/diagnosis , Neoplasm Proteins/biosynthesis , Neoplasm Staging , Plasmacytoma/diagnosis , Prognosis , Protein BiosynthesisABSTRACT
The t(4;14) (p16; q32) with fusion of the IGH (immunoglobulin heavy chain) and FGFR3 (fibroblast growth factor receptor 3) genes are rarely present in patients with chronic lymphocytic leukemia (CLL), with only two previously reported cases. We herein describe a unique case of CLL with the occurrence of a t(4;14) (p16;q32), trisomy 12, and deletion of 11q13-q23 in the same clonal cells. In contrast to myeloma, in which FGFR3 translocations are a common early cytogenetic hit, FGFR3 rearrangement in CLL appears to occur later in the disease course.
Subject(s)
Gene Rearrangement , Immunoglobulin Heavy Chains/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Receptor, Fibroblast Growth Factor, Type 3/genetics , Translocation, Genetic/genetics , Aged , Chromosomes, Human, Pair 11/genetics , Chromosomes, Human, Pair 12/genetics , Chromosomes, Human, Pair 14/genetics , Chromosomes, Human, Pair 4/genetics , Cytogenetic Analysis , Disease Progression , Fatal Outcome , Flow Cytometry , Humans , In Situ Hybridization, Fluorescence , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Male , Polymerase Chain Reaction , Review Literature as Topic , Trisomy/geneticsABSTRACT
We present a unique case of a patient with a clinical history of distal esophageal carcinoma and CT appearance of lipomatous hypertrophy of the interatrial septum who displayed fluorine-18-fluorodeoxyglucose (FDG) uptake in the interatrial septal fat on only the second of 4 serial PET/CT studies. As PET/CT scans are used for the initial staging of esophageal carcinoma, one should not mistake more benign causes of mediastinal uptake for metastasis when observing an intermittent pattern of uptake on a PET/CT scan.
Subject(s)
Cardiomegaly/diagnosis , Cardiomegaly/metabolism , Fluorodeoxyglucose F18/metabolism , Heart Septum/metabolism , Lipoma/diagnosis , Lipoma/metabolism , Aged , Carcinoma/diagnostic imaging , Carcinoma/metabolism , Carcinoma/pathology , Cardiomegaly/diagnostic imaging , Diagnosis, Differential , Esophageal Neoplasms/diagnostic imaging , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Heart Septum/diagnostic imaging , Heart Septum/pathology , Humans , Lipoma/diagnostic imaging , Male , Neoplasm Staging , Positron-Emission Tomography , Time Factors , Tomography, X-Ray ComputedABSTRACT
Diagnosing Lyme arthritis without a history of travel to endemic regions or erythema migrans can be a challenge. Radiographic and ultrasonographic findings are nonspecific for the diagnosis of Lyme arthritis. We present the MRI features of Lyme disease of the hip in a 4-year-old boy who presented with hip pain and was found to have Lyme disease by Western blot. Our findings include bilateral hip effusions and synovial enhancement, normal bone marrow signal intensity without enhancement, minimal adjacent muscular and soft-tissue edema, and bilateral inguinal lymph nodes measuring up to 1 cm.
Subject(s)
Arthralgia/diagnosis , Arthralgia/etiology , Lyme Disease/complications , Lyme Disease/diagnosis , Magnetic Resonance Imaging/methods , Osteoarthritis, Hip/complications , Osteoarthritis, Hip/diagnosis , Child, Preschool , Hip Joint/pathology , Humans , MaleABSTRACT
Here we show that patients with myelodysplastic syndromes (MDS) have a severe deficiency of glycolipid reactive Valpha24+/Vbeta11+ natural killer T (NKT) cells, but not NK cells or CD4+ or CD8+ T cells. Neither the blood nor marrow of MDS patients had detectable interferon-gamma-producing NKT cells in response to the NKT ligand, alpha-galactosyl ceramide, although influenza-virus-specific effector T-cell function was preserved. This severe and selective deficiency of an important immune regulatory cell may contribute to the pathogenesis of MDS.